For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts
Read more about: natco

Shares in Natco Rally On Hepatitis Approval

|

Shares in Natco rallied after the company received an approval for generic Hepatitis C medicine. The stock was up over 5 per cent at Rs 1,963 on the National Stock Exchange.

 

Shares in Natco Rally On Hepatitis Approval
Natco Pharma: Quotes, News
BSE 927.00BSE Quote2.95 (0.32%)
NSE 927.45NSE Quote2.7 (0.29%)
It also hit a new 52-week high of Rs 1984 in intra day trading.

"Natco Pharma is pleased to announce that it is the 1st company in India to get approval for generic sofosbuvir tablets, 400mg, from Drugs Controller General (India)," the company said in a press release.

GoodReturns.in

Story first published: Thursday, March 12, 2015, 12:20 [IST]
Company Search
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X